What podcasts say about Tiwa Adebayo
Every statement, with the speaker, the exact quote and the moment it was said.
What Tiwa Adebayo has said on podcasts
61 statements · 34 positive · 26 negative · 1 mixed
Tesco shares rose as much as 3.3% after positive results and forecasts
“their shares are up by as much as about 3.3%”
Open the episode · Tesco Climbs, Imperial Brands Rises, Zealand Pharma SlipsListen at 0:44
Imperial Brands faces declining smoking and mounting regulatory challenges
“Imperial Brands really grappling with the decline that we're seeing in smoking and also mounting regulatory challenges”
Open the episode · Tesco Climbs, Imperial Brands Rises, Zealand Pharma SlipsListen at 2:49
Petrelatide trial results were unfavorable and showed high discontinuation rates
“Petrelatide, had trial results which haven't been super positive, showing high discontinuation rates”
Open the episode · Tesco Climbs, Imperial Brands Rises, Zealand Pharma SlipsListen at 3:33
Positive clinical results are reducing uncertainty around Genmab’s sales expectations.
“these positive results are helping to de-risk sales expectations”
Open the episode · Genmab Gains, Sabadell Rises, Vend TumblesListen at 1:27
BPCE’s Sabadell investment advances its international business expansion.
“it is this next move to expand the business”
Open the episode · Genmab Gains, Sabadell Rises, Vend TumblesListen at 2:39
Sabadell gains a large shareholder interested in its distribution capabilities.
“for Sabadell, it means it's getting another large shareholder interested in its distribution capabilities”
Open the episode · Genmab Gains, Sabadell Rises, Vend TumblesListen at 2:42
BPCE’s investment is favorable news for Banco Sabadell.
“So it's good news for Sabadell.”
Open the episode · Genmab Gains, Sabadell Rises, Vend TumblesListen at 2:54
Schneider Electric shares are falling about 9% in current trading.
“We're seeing shares falling by about 9% now in trading.”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 1:12
Schneider Electric is expanding through acquisitions to profit from AI-driven factory modernization.
“we've seen Schneider expanding through these acquisitions in recent months, a bid to profit from that accelerating push to modernize factories as manufacturers increasingly implement AI.”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 1:26
Hermès’s Birkin bag is not experiencing the weakness affecting other categories.
“the very, famous Birkin bag is not taking a hit”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 2:36
Secondary-market availability may dilute Hermès’s exclusivity.
“perhaps diluting the exclusivity that Hermès has to offer.”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 3:12
- on Intesa Sanpaolo offer for Mediobanca and Monte dei Paschi di SienaPositiveOct 5, 2026· Stock Movers
Intesa Sanpaolo’s improved offer is increasing the likelihood of the transaction closing.
“increasing the likelihood of that closing.”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 3:45
Unipol shares are approximately 3.8% higher after the deal news.
“Unipol is around 3.8% higher after this news.”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 3:47
Unipol is outperforming its peers today.
“Unipol is the best performer amongst its peers today”
Open the episode · Schneider Keeps Dropping, Hermès Dips, Unipol GainsListen at 4:10
UK housebuilders are surging following the first-time-buyer loan announcement
“UK housebuilders are really surging this morning”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 1:00
Rexel shares rose as much as approximately 4.3%
“Rexel advancing as much as about 4.3% this morning”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 2:29
Analysts say Rexel’s GCG acquisition improves North American and data-center exposure
“That deal is seen as a good strategic fit by analysts, improving the company's North America exposure and its position in markets such as data centers”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 2:46
Erste Bank could fund the stake increase by canceling dividends.
“It's thought that the bank could fund this increase by canceling dividends.”
Open the episode · Barratt Redrow Jumps, Erste Bank Up, Fresnillo DipsListen at 2:49
European mining stocks are declining
“European miners dropping”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 3:30
Slower Chinese industrial-profit growth is contributing to European miners’ decline
“this is specifically tied to data that is showing slower growth in industrial profits in China”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 3:36
The Stoxx 600 Basic Resources Index fell just over 2%, worst in the region
“The Stoxx 600 Basic Resources Index about just over 2% lower this morning is the worst performing sector in the region”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 3:45
The Stoxx 600 Basic Resources Index fell 2.2% that morning.
“The Stoxx 600 Basic Resources Index, which is the index that encapsulates the miners as well, this was 2.2% lower this morning.”
Open the episode · Barratt Redrow Jumps, Erste Bank Up, Fresnillo DipsListen at 3:45
The Stoxx 600 Basic Resources Index trades at its lowest level since early August
“that gauge is trading at its lowest level since early August as well”
Open the episode · Persimmon Gains, Rexel Rises, Fresnillo DownListen at 3:54
The Stoxx 600 Basic Resources Index traded at its lowest level since early August.
“And that gauge is actually trading at its lowest level since the beginning of August as well.”
Open the episode · Barratt Redrow Jumps, Erste Bank Up, Fresnillo DipsListen at 3:58
AstraZeneca’s breast-cancer pill trial failed, potentially reducing the drug’s sales by billions.
“a recent breast cancer pill trial has failed and it could cut several billion dollars from the drug's potential sales.”
Open the episode · GSK Jumps, Astrazeneca UpListen at 2:05
AstraZeneca’s drug did not outperform standard treatment in delaying disease progression.
“drug failed to delay the disease progression more than the standard treatment in a late-stage study.”
Open the episode · GSK Jumps, Astrazeneca UpListen at 2:14
Novartis’s muscle-wasting disease treatment failed its phase-three primary endpoint.
“a treatment that they were developing for a muscle-wasting disease has failed to meet the primary endpoint in a phase three trial”
Open the episode · Novartis Slumps, Rubis Gains, Computacenter UpListen at 1:00
Computacenter may exemplify Britain’s AI opportunity.
“Computer Centre might be one of the shining examples of that in a UK context”
Open the episode · Novartis Slumps, Rubis Gains, Computacenter UpListen at 3:22
Rubis has benefited from elevated energy prices supporting unit margins.
“it has benefited from these elevated energy prices that we're seeing that supported unit margins”
Open the episode · Novartis Slumps, Rubis Gains, Computacenter UpListen at 4:22
Ackermans reported higher net income, core-segment contribution, and positive growth capital.
“consolidated net income up 24%, with contribution from core segments rising by 13%, and growth capital recovering to a positive 21.4 million euros”
Open the episode · Ackermans Rises, Legrand Gains, EssilorLuxotica UpListen at 1:10
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.